IT1245717B - Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche - Google Patents

Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche

Info

Publication number
IT1245717B
IT1245717B IT02096890A IT2096890A IT1245717B IT 1245717 B IT1245717 B IT 1245717B IT 02096890 A IT02096890 A IT 02096890A IT 2096890 A IT2096890 A IT 2096890A IT 1245717 B IT1245717 B IT 1245717B
Authority
IT
Italy
Prior art keywords
treatment
delphidin
pelargonidin
antocyanidine
compound based
Prior art date
Application number
IT02096890A
Other languages
English (en)
Other versions
IT9020968A1 (it
IT9020968A0 (it
Inventor
Maria Jose Magistretti
Marisa Conti
Giorgio Pifferi
Original Assignee
Idb Holding Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idb Holding Spa filed Critical Idb Holding Spa
Publication of IT9020968A0 publication Critical patent/IT9020968A0/it
Publication of IT9020968A1 publication Critical patent/IT9020968A1/it
Application granted granted Critical
Publication of IT1245717B publication Critical patent/IT1245717B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
IT02096890A 1989-07-28 1990-07-18 Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche IT1245717B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917323A GB8917323D0 (en) 1989-07-28 1989-07-28 Methods and pharmaceutical compositions for the treatment of ophthalmic diseases

Publications (3)

Publication Number Publication Date
IT9020968A0 IT9020968A0 (it) 1990-07-18
IT9020968A1 IT9020968A1 (it) 1992-01-18
IT1245717B true IT1245717B (it) 1994-10-14

Family

ID=10660801

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02096890A IT1245717B (it) 1989-07-28 1990-07-18 Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche

Country Status (11)

Country Link
US (1) US5196449A (it)
EP (1) EP0410749B1 (it)
JP (1) JP2967523B2 (it)
KR (1) KR0149026B1 (it)
AT (1) ATE112960T1 (it)
DE (1) DE69013431T2 (it)
DK (1) DK0410749T3 (it)
GB (1) GB8917323D0 (it)
HK (1) HK124595A (it)
IT (1) IT1245717B (it)
PT (1) PT94848A (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673513B1 (fr) * 1991-03-05 1993-10-29 Institut Recherche Biologique Sa Nouvelles compositions dietetiques a base de lipides phosphoryles et leur utilisation dans l'amelioration des troubles de la vision.
JP3414446B2 (ja) * 1993-07-23 2003-06-09 財団法人相模中央化学研究所 ヒドロキシシリル基を末端に有するポリオキシエチレン化合物、四級塩を末端に有するブロック共重合体、および経皮吸収促進剤
JPH1059846A (ja) * 1996-06-10 1998-03-03 Kikkoman Corp 白内障の予防または治療薬剤
JP3455528B2 (ja) * 1999-07-02 2003-10-14 明治製菓株式会社 食品用組成物、その製造法およびそれを含む機能性飲食品
FR2811550B1 (fr) * 2000-07-11 2003-02-14 Oreal Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux
US7014991B2 (en) * 2001-11-16 2006-03-21 Infinite Vision, Llc Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface
WO2005042555A1 (ja) 2003-10-30 2005-05-12 Meiji Seika Kaisha, Ltd. チロシナーゼ活性阻害剤及び顔面血流改善剤
JP4873904B2 (ja) * 2005-08-22 2012-02-08 国立大学法人弘前大学 眼血管血流障害改善剤
FR2975008B1 (fr) * 2011-05-13 2014-03-07 Inst Biophytis Utilisation de composes et composition pour le traitement de la degenerescence maculaire liee a l'age (dmla)
JP2013163669A (ja) * 2012-01-12 2013-08-22 Oriza Yuka Kk 可視光誘発網膜障害抑制剤及びそれを用いた眼疾患予防・治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
FR2378272A1 (fr) * 1977-01-25 1978-08-18 Ferodo Sa Dispositif dynamometrique de mesure de couple pour engin a fleche de levage a commande par verin
BE864450R (fr) * 1978-03-01 1978-07-03 Inverni Della Beffa Spa Compositions pharmaceutiques a base d'anthocyanidine, leur preparation et leur utilisation
FR2461499A1 (fr) 1979-07-23 1981-02-06 Inverni Della Beffa Spa Composition pharmaceutique a base d'extraits de myrtille
EP0258476B1 (en) * 1986-09-02 1990-04-25 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2

Also Published As

Publication number Publication date
KR0149026B1 (ko) 1998-10-15
PT94848A (pt) 1991-04-18
KR910002442A (ko) 1991-02-25
GB8917323D0 (en) 1989-09-13
IT9020968A1 (it) 1992-01-18
JP2967523B2 (ja) 1999-10-25
EP0410749A2 (en) 1991-01-30
EP0410749B1 (en) 1994-10-19
EP0410749A3 (en) 1993-02-03
HK124595A (en) 1995-08-11
DE69013431D1 (de) 1994-11-24
DK0410749T3 (da) 1994-11-14
DE69013431T2 (de) 1995-02-23
JPH0381220A (ja) 1991-04-05
US5196449A (en) 1993-03-23
IT9020968A0 (it) 1990-07-18
ATE112960T1 (de) 1994-11-15

Similar Documents

Publication Publication Date Title
DE69019111D1 (de) Ascorbinsäure-Tocopheryl-Phosphatdiester zur Hemmung der Maillard-Reaktion.
DE69939705D1 (de) Behandlung der pompeschen krankheit
AU549481B2 (en) Hair growing agent
NO912410D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
EP0249735A3 (en) Pharmaceutical preparations comprising as active agent 2-phenyl-1.2-benzisoselenazol-3(2h)-one, for the treatment of diseases caused by oxidative stress
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
DE69426334D1 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
KR100260061B1 (en) Vitamin e drop
DK0412554T3 (da) Sustained-release-præparat til administration i hjernen
DK0410749T3 (da) Anthocyanidiner til behandling af ophthalmiske sygdomme
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
FI924744A0 (fi) Terapeutiska aemnen
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
IT1223395B (it) Composti ad attivita' cardiovascolare
SE8200748L (sv) Terapeutiskt medel
ATE258229T1 (de) Substanz fa-70d, herstellungsverfahren und verwendungen
GR3017672T3 (en) Therapeutic agent for diabetic gangrene.
HU911272D0 (en) Process for the production of medical preparations containing hexetidine

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970728